A Multicenter, Retrospective, Observational Study Using Real-world Data to Describe the Safety, Treatment Pattern and Effectiveness of Nirmatrelvir/Ritonavir among Patients treated with Nirmatrelvir/Ritonavir in China

First published 16/03/2023

Last updated 26/11/2024

EU PAS number:

EUPAS103409

Study

Finalised

Documents

Study protocol

Initial protocol

C4671043_Protocol-5Dec2022-Redacted

English (7.32 MB - PDF)View document

Updated protocol

C4671043_Protocol-5Dec2022-full protocol.pdf

First published: 26/11/2024

English (7.31 MB - PDF)View document

Study results

Study report

C4671043 Paxlovid NI Clinical Study Report_redacted.pdf

English (805.02 KB - PDF)View document

C4671043 Paxlovid NI Clinical Study Report Abstract_redacted.pdf

English (400.64 KB - PDF)View document

Other information

Secondary tabs